BioSpace News Archive

Deals

ObsEva Announces Change of Central Securities Depositary

ObsEva SA today announced that it intends for its common shares to be traded under a new International Securities Identification Numbers (“ISIN”) beginning on April 25, 2023.

April 20, 2023

·

5 min read

Orphalan announces US commercial launch of Cuvrior™ for the treatment of Wilson disease

Orphalan SA today announces the commercial launch in the US of Cuvrior™, a new trientine tetrahydrochloride (TETA-4HCl).

April 20, 2023

·

3 min read

Genetown

Cullinan Oncology to Participate in Stifel’s 2023 Targeted Oncology Days

Cullinan Oncology, Inc. today announced that its President and Chief Executive Officer, Nadim Ahmed, will participate in a fireside chat at the Stifel 2023 Targeted Oncology Days on April 26, 2023, at 2:30 PM EDT.

April 20, 2023

·

1 min read

Business

iSpecimen to Report First Quarter 2023 Results on May 4, 2023

iSpecimen Inc. today announced that it will report its financial results for the first quarter ended March 31, 2023 before the market opens on Thursday, May 4, 2023.

April 20, 2023

·

3 min read

Samsung Bioepis to Present New Data for SB15, a proposed biosimilar to Eylea (aflibercept), at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Samsung Bioepis Co., Ltd. today announced that it will present new data on SB15, a proposed biosimilar to Eylea 1 (aflibercept), at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.

April 20, 2023

·

2 min read

Biotech Beach

PreludeDx™ to Present Comparative Analysis of Treatment Recommendations of Black and White DCIS Breast Cancer Patients Using DCISionRT® at ASBrS 2023 Annual Meeting

Prelude Corporation today announced it will be presenting data using DCISionRT ® to examine the decision impact on physician recommendation for adjuvant radiation therapy by race (White vs. Black) in women with ductal carcinoma in situ (DCIS) enrolled in the PREDICT study.

April 20, 2023

·

3 min read

Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting

Bausch + Lomb Corporation today announced the presentation of eight scientific poster presentations during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place in New Orleans from April 23-27, 2023.

April 20, 2023

·

6 min read

Drug Development

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD ™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases.

April 20, 2023

·

15 min read

Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals

Tesis Biosciences has announced a new predictive genomic assay that will allow physicians to more accurately identify appropriate drug therapies and dosages for patients suffering from hundreds of diseases and conditions.

April 20, 2023

·

3 min read

Pharm Country

Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday, April 21, 2023, at 3:30 p.m. ET.

April 20, 2023

·

1 min read